Investor’s Delight: Vaxcyte Inc (PCVX) Closes Weak at 115.61, Down -1.97

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Vaxcyte Inc (NASDAQ: PCVX) was $115.61 for the day, down -1.97% from the previous closing price of $117.93. In other words, the price has decreased by -$1.97 from its previous closing price. On the day, 0.59 million shares were traded. PCVX stock price reached its highest trading level at $118.54 during the session, while it also had its lowest trading level at $115.45.

Ratios:

Our analysis of PCVX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 17.88 and its Current Ratio is at 17.88. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 07, 2023, initiated with a Buy rating and assigned the stock a target price of $69.

Needham reiterated its Buy rating for the stock on January 03, 2023, while the target price for the stock was revised from $52 to $58.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 07 ’24 when PICKERING GRANT sold 7,098 shares for $109.21 per share. The transaction valued at 775,154 led to the insider holds 138,581 shares of the business.

Eydelman Mikhail sold 5,000 shares of PCVX for $546,353 on Oct 07 ’24. The SVP, GEN COUNSEL & CORP SEC now owns 28,623 shares after completing the transaction at $109.27 per share. On Oct 07 ’24, another insider, PICKERING GRANT, who serves as the Officer of the company, bought 7,098 shares for $111.12 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCVX now has a Market Capitalization of 14310552576 and an Enterprise Value of 11476077568.

Stock Price History:

Over the past 52 weeks, PCVX has reached a high of $121.06, while it has fallen to a 52-week low of $45.00. The 50-Day Moving Average of the stock is 13.71%, while the 200-Day Moving Average is calculated to be 47.37%.

Shares Statistics:

PCVX traded an average of 938.10K shares per day over the past three months and 616410 shares per day over the past ten days. A total of 121.80M shares are outstanding, with a floating share count of 117.11M. Insiders hold about 3.86% of the company’s shares, while institutions hold 98.05% stake in the company. Shares short for PCVX as of 1727654400 were 9651135 with a Short Ratio of 10.29, compared to 1724976000 on 10298601. Therefore, it implies a Short% of Shares Outstanding of 9651135 and a Short% of Float of 8.8599995.

Most Popular